Aktuellt
SENASTE
Redeye notes that Q1 sales were slightly lower than our estimates; however, EBIT aligned with our forecast. Furthermore, we will release a research update where we will dig deeper into the report and last week’s major milestone: the FDA clearance of Aurora AEYE.
LÄS MER
